NIH-funded research R21 grant

How a brain protein complex helps nerve cells form connections and relates to autism

Official title: The BAF chromatin remodeling complex in experience-induced neuronal gene transcription and synapse maturation; implications for autism spectrum disorders

Funded at University of California, Merced · NIH-11251937 · Data updated 2026-11-12

Researchers are looking at how a brain protein complex called nBAF helps nerve cells turn on genes and form connections, which may be important for children with autism linked to specific gene changes.

More Autism research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California, Merced
NIH-funded
Lab location1 site (Merced, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2026
Funding year2026
Award (this year)$198,125
NIH project number5R21MH139062-02
Project IDNIH-11251937 on NIH RePORTER

Who could benefit from this research

Could help

Children with autism who have known loss-of-function mutations in BAF complex genes (for example SMARCC2 or ARID1A) would be most directly relevant to this work.

Less likely to help

People with autism who do not carry mutations in BAF complex genes or those seeking immediate treatment options are unlikely to see direct benefits from this basic lab work.

What this research studies

As a parent, it's helpful to know these scientists will focus on a gene called SMARCC2 and the larger BAF protein complex that genetic studies have linked to autism. They will use lab-grown neurons and animal models to see how this protein helps the cell's gene-copying machinery finish its work and how that affects synapse maturation. The team will study flexible protein regions that let parts of the complex stick together and form functional assemblies in maturing brain cells. Findings aim to explain how certain gene changes can disrupt early brain development.

Why it matters

Potential benefit: If successful, this work could point to specific molecular targets for future therapies that support synapse development in some forms of autism.

How similar studies have gone: Genetic studies have repeatedly linked BAF complex subunits to autism, but mechanistic laboratory work on how these proteins control gene expression and synapse development is still early and largely preclinical.

Where this research is happening

  • University of California, Merced
    Merced, United States
    Active

Researchers

  • Principal investigator: Saha, Ramendra N — University of California, Merced
  • Study coordinator: Saha, Ramendra N

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.